(Q43105039)

14 November 2017

Carcinogenesis of PIK3CA. (English)

1 reference

14 November 2017

1 reference

Sidra German

1

1 reference

14 November 2017

Hafiz Muhammad Aslam

2

1 reference

14 November 2017

Shafaq Saleem

3

1 reference

14 November 2017

Aisha Raees

4

1 reference

14 November 2017

Tooba Anum

5

1 reference

14 November 2017

Arsalan Ahmad Alvi

6

1 reference

14 November 2017

Abdul Haseeb

7

1 reference

14 November 2017

15 June 2013

1 reference

Hereditary Cancer in Clinical Practice

14 November 2017

1 reference

14 November 2017

11

1 reference

14 November 2017

5

1 reference

14 November 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1186/1897-4287-11-5

14 November 2017

0 references

cites work

Chordoma characterization of significant changes of the DNA methylation pattern

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702456

Germline PIK3CA and AKT1 mutations in Cowden and Cowden-like syndromes

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702456

Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702456

A phosphatidylinositol 3-kinase-Pax3 axis regulates Brn-2 expression in melanoma

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702456

Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702456

PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702456

The PI3K pathway as drug target in human cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702456

Actin cytoskeletal mediators of motility and invasion amplified and overexpressed in head and neck cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702456

Clinicopathological analysis of papillary thyroid cancer with PIK3CA alterations in a Middle Eastern population

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702456

Correlation of PIK3Ca mutations with gene expression and drug sensitivity in NCI-60 cell lines

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702456

Mutation of the PIK3CA gene in anaplastic thyroid cancer.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702456

Signalling through phosphoinositide 3-kinases: the lipids take centre stage

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702456

Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702456

High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702456

PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702456

Frequent alterations of the PI3K/AKT/mTOR pathways in hereditary nonpolyposis colorectal cancer

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702456

Genetic alterations in the PI3K pathway in prostate cancer.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702456

Mutations of the PIK3CA gene in hereditary colorectal cancers.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702456

PIK3CA gene mutations in pediatric and adult glioblastoma multiforme.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702456

Mutations of PIK3CA in Anaplastic Oligodendrogliomas, High-Grade Astrocytomas, and Medulloblastomas

15 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1897-4287-11-5

Uncommon Mutation, but Common Amplifications, of thePIK3CAGene in Thyroid Tumors

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1897-4287-11-5

21 January 2018

Identifiers

DOI

10.1186/1897-4287-11-5

1 reference

Dimensions Publication ID

14 November 2017

0 references

1 reference

14 November 2017

1 reference